Product Description
Basic Info.
ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes.ARA 290 has been shown to be effective in the reduction of inflammation and activation of the healing process in a wide variety of preclinical models as well as in patients.
With respect to diabetes, substantial recent work has shown that rhEPO can improve the diabetic state in animal models . However, in addition to interacting with the innate repair receptor in a paracrine/autocrine manner, EPO also functions as a circulating hormone via its interaction with the EPO receptor homodimer that mediates hematopoiesis.
Factory
Well-Equipped Filter Physical and Chemical Laboratory
To solidify product qualityfoundations and establishan industry-leading r&Dand testing system,the companyinvested in2014to
build a wel-equipped, fully-functional provincial-level filter physical and chemical laboratory. Designed and constructed in strict accor-
dance with the highest national and industry standards, the laboratory is outfitted with world-class precision testing instruments and
experimental equipment.
In 2016, leveraging its exceptional quality management capabilities and standardized production operations, the company successfully
achieved ISO/Ts 16949:2009 certification-the most authoritative quality management system recognized by the global automotive in-
dustry--becoming one of the select few enterprises in the sector to earn this distinguished honor.

















